Histidine-Rich Glycoprotein Protects from Systemic Candida Infection
2008

Histidine-Rich Glycoprotein Protects from Systemic Candida Infection

Sample size: 6 publication 10 minutes Evidence: high

Author Information

Author(s): Victoria Rydengård, Oanagh Shannon, Katarina Lundqvist, Lukasz Kacprzyk, Anna Chalupka, Anna-Karin Olsson, Matthias Mörgelin, Willi Jahnen-Dechent, Martin Malmsten, Artur Schmidtchen

Primary Institution: Lund University, Biomedical Center, Lund, Sweden

Hypothesis

Can histidine-rich glycoprotein (HRG) provide protection against systemic Candida infections?

Conclusion

The study demonstrates that histidine-rich glycoprotein plays a key antifungal role in innate immunity.

Supporting Evidence

  • HRG was shown to bind to Candida cells and induce breaks in their cell walls.
  • HRG's antifungal activity was enhanced at low pH.
  • Hrg−/− mice were more susceptible to Candida infection compared to wild-type mice.
  • HRG was detected in human plasma and fibrin clots, indicating its physiological relevance.

Takeaway

Histidine-rich glycoprotein helps our body fight off infections from a type of fungus called Candida, especially when the environment is acidic.

Methodology

The study used microbiological, biochemical, and biophysical methods to assess the antifungal activity of HRG against various Candida strains.

Statistical Information

P-Value

p=0.02

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.ppat.1000116

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication